Erhart, Friedrich http://orcid.org/0000-0002-9708-3126
Hackl, Matthias
Hahne, Hannes
Buchroithner, Johanna
Meng, Chen
Klingenbrunner, Simone
Reitermaier, René
Fischhuber, Katrin
Skalicky, Susanna
Berger, Walter
Spiegl-Kreinecker, Sabine
Lötsch, Daniela
Ricken, Gerda
Kuster, Bernhard
Wöhrer, Adelheid
Widhalm, Georg
Hainfellner, Johannes
Felzmann, Thomas
Dohnal, Alexander M.
Marosi, Christine
Visus, Carmen
Funding for this research was provided by:
Austrian Society of Hematology and Oncology (ASHO) Research Grant 2013
Activartis Biotech GmbH
Article History
Received: 9 July 2019
Accepted: 25 November 2019
First Online: 16 January 2020
Competing interests
: C.V., S.K., K.F. and R.R. were employees of Activartis Biotech GmbH at the time of this investigation. F.E. and A.M.D. were formerly (part‐time) employees of Activartis Biotech GmbH. The authors declare that the research was conducted in the absence of any other commercial, financial or personal relationships that could be construed as a potential competing interest.